TR1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
||||
1. Identity of the issuer or the underlying issuer |
Provexis plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
X |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
|
|||
Other (please specify): |
|
|
||
3. Full name of person(s) subject to the |
ANGLE plc |
|||
4. Full name of shareholder(s) |
ANGLE Technology Limited Progeny bioVentures Limited |
|||
5. Date of the transaction and date on |
30 June 2009 and 1 July 2009 |
|||
6. Date on which issuer notified: |
1 July 2009 |
|||
7. Threshold(s) that is/are crossed or |
Falls below 6% |
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of |
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
Ordinary shares ISIN code GB00B0923P27 |
65,145,643 |
65,145,643 |
42,395,643 |
42,395,643 |
|
5.2% |
|
|||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to |
% of voting rights xix, xx |
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
42,395,643 |
5.2% |
9. Chain of controlled undertakings through which the voting rights and/or the |
||
The ordinary shares in Provexis plc are owned by: ANGLE Technology Limited - in respect of 20,426,464 shares Progeny bioVentures Limited - in respect of 21,969,179 shares ANGLE plc owns: 100% of ANGLE Technology Limited; and 96.5% of Progeny bioVentures Limited |
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
13. Additional information: |
|
|
14. Contact name: |
Ian Griffiths |
|
15. Contact telephone number: |
01483 685830 |